METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m<sup>6</sup>A modification of ANKRD22 mRNA - Concepedia

Concepedia

Publication | Open Access

METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m<sup>6</sup>A modification of ANKRD22 mRNA

DOI Full Paper Access

19

Citations

50

References

2024

Year

Lvyuan Li, Qiling Tang, Junshang Ge, Dan Wang, Yongzhen Mo, Yijie Zhang, Yumin Wang, Fang Xiong, Qijia Yan, Qianjin Liao,

Clinical and Translational Medicine

Abstract

The identified METTL14-ANKRD22-SLC25A1 axis emerges as a promising therapeutic target for NPC, and also these molecules may serve as novel diagnostic biomarkers.

References

	Year	Citations

Page 1